+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, Orthopedics, Musculoskeletal & Spine, Dental, Urology, Cardiology & Vascular), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 4538854
Description Jump to:
The global tissue engineering market size is estimated to reach USD 43.13 billion by 2030, growing at an estimated CAGR of 14.28% from 2023 to 2030. Growing incidence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic disorders, has driven the demand for tissue engineering solutions that can repair or replace damaged tissues. Advances in biomaterials, 3D bioprinting, stem cell research, and gene editing techniques have propelled the field of tissue engineering, enabling the development of complex and functional tissues.

The allogeneic tissue transplant method effectively addresses the challenges and limitations associated with the use and accessibility of autologous transplants. In addition, the advancement of specialized procedures, such as implant fixing and sterilization, aimed at converting allogeneic implants into biostatic implants, is anticipated to boost revenue generation in this market.

Tissue regeneration technology is gaining popularity due to its effective products and low rejection rates, leading to an increase in regeneration treatments. Pre-clinical research is currently focused on the use of tissue-engineered vascular grafts in cardiovascular surgery and treatment. Moreover, tissue-engineered bladders can now be successfully implanted outside of the patient's body. Despite these advancements, the market's growth is hindered by challenges such as the high cost of product development and ethical concerns surrounding stem cell research and tissue-engineered products.

Tissue Engineering Market Report Highlights

  • In terms of application, the orthopedics, musculoskeletal, and spine segment held the largest revenue share of 59.76% in 2022 owing to the rising prevalence of musculoskeletal disorders. Tissue engineering has emerged as a crucial therapy option for orthopedic surgeons in the management of several musculoskeletal disorders, ranging from meniscal deficits in young athletes to osteochondral abnormalities in the glenohumeral joint
  • The cardiology & vascular segment is anticipated to grow at the fastest CAGR of 25.94% over the forecast period, owing to a rapid increase in the prevalence of cardiovascular disorders globally
  • For the past two decades, cardiac cell therapy or cardiomyoplasty has been a significant focal point in the majority of studies aimed at managing heart disease through regeneration
  • The increasing prevalence of children with congenital malformations, including single ventricle anomalies, has resulted in a rising demand for heart transplantation
  • In terms of region, North America held the largest revenue share of 51.23% in 2022 due to a rise in awareness for stem cell therapy as well as a growing geriatric population
  • Asia Pacific is anticipated to grow at the fastest CAGR of 15.84% over the forecast period due to the presence of untapped opportunities in the emerging economies of China and India


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Tissue Engineering Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Advancements in stem cell technology & tissue engineering
3.4.1.2. Rise in the number of clinical studies for regenerative medicine and tissue engineering
3.4.1.3. Increasing tissue engineering research funding
3.4.2. Market restraint analysis
3.4.2.1. High cost of product development
3.4.2.2. Ethical concerns related to stem cell research & tissue engineered product
3.4.2.3. Clinical issues pertaining to development & implementation of stem cell therapies
3.5. Tissue Engineering Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. COVID-19 Impact Analysis
Chapter 4. Tissue Engineering Market: Application Estimates & Trend Analysis
4.1. Global Tissue Engineering Market Application Movement Analysis
4.2. Cord blood & Cell banking
4.2.1. Cord blood & Cell banking market estimates and forecast 2018 to 2030 (USD Billion)
4.3. Cancer
4.3.1. Cancer market estimates and forecast 2018 to 2030 (USD Billion)
4.4. GI/Gynecology
4.4.1. GI/Gynecology therapy market estimates and forecast 2018 to 2030 (USD Billion)
4.5. Dental
4.5.1. Dental market estimates and forecast 2018 to 2030 (USD Billion)
4.6. Skin & Integumentary
4.6.1. Skin & Integumentary market estimates and forecast 2018 to 2030 (USD Billion)
4.7. Urology
4.7.1. Urology market estimates and forecast 2018 to 2030 (USD Billion)
4.8. Orthopedics, Musculoskeletal, & Spine
4.8.1. Orthopedics, Musculoskeletal, & Spine market estimates and forecast 2018 to 2030 (USD Billion)
4.9. Neurology
4.9.1. Neurology market estimates and forecast 2018 to 2030 (USD Billion)
4.10. Cardiology & Vascular
4.10.1. Cardiology & Vascular market estimates and forecast 2018 to 2030 (USD Billion)
4.11. Others
4.11.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
Chapter 5. Tissue Engineering Market: Regional Estimates & Trend Analysis
5.1. Tissue Engineering Market: Share By Region, 2022 & 2030
5.2. North America
5.2.1. SWOT Analysis
5.2.2. North America Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.2.3. U.S.
5.2.3.1. Key Country Dynamics
5.2.3.2. Competitive Scenario
5.2.3.3. Regulatory Framework
5.2.3.4. U.S. Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.2.4. Canada
5.2.4.1. Key Country Dynamics
5.2.4.2. Competitive Scenario
5.2.4.3. Regulatory Framework
5.2.4.4. Canada Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.3. Europe
5.3.1. SWOT Analysis
5.3.2. Europe Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.3.3. UK
5.3.3.1. Key Country Dynamics
5.3.3.2. Competitive Scenario
5.3.3.3. Regulatory Framework
5.3.3.4. UK Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.3.4. Germany
5.3.4.1. Key Country Dynamics
5.3.4.2. Competitive Scenario
5.3.4.3. Regulatory Framework
5.3.4.4. Germany Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.3.5. France
5.3.5.1. Key Country Dynamics
5.3.5.2. Competitive Scenario
5.3.5.3. Regulatory Framework
5.3.5.4. France Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.3.6. Italy
5.3.6.1. Key Country Dynamics
5.3.6.2. Competitive Scenario
5.3.6.3. Regulatory Framework
5.3.6.4. Italy Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.3.7. Spain
5.3.7.1. Key Country Dynamics
5.3.7.2. Competitive Scenario
5.3.7.3. Regulatory Framework
5.3.7.4. Spain Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.3.8. Sweden
5.3.8.1. Key Country Dynamics
5.3.8.2. Competitive Scenario
5.3.8.3. Regulatory Framework
5.3.8.4. Sweden Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.3.9. Norway
5.3.9.1. Key Country Dynamics
5.3.9.2. Competitive Scenario
5.3.9.3. Regulatory Framework
5.3.9.4. Norway Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.3.10. Denmark
5.3.10.1. Key Country Dynamics
5.3.10.2. Competitive Scenario
5.3.10.3. Regulatory Framework
5.3.10.4. Denmark Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.4. Asia Pacific
5.4.1. SWOT Analysis
5.4.2. Asia Pacific Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.4.3. China
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. China Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.4.4. Japan
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. Japan Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.4.5. India
5.4.5.1. Key Country Dynamics
5.4.5.2. Competitive Scenario
5.4.5.3. Regulatory Framework
5.4.5.4. India Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.4.6. Australia
5.4.6.1. Key Country Dynamics
5.4.6.2. Competitive Scenario
5.4.6.3. Regulatory Framework
5.4.6.4. Australia Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.4.7. Thailand
5.4.7.1. Key Country Dynamics
5.4.7.2. Competitive Scenario
5.4.7.3. Regulatory Framework
5.4.7.4. Thailand Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.4.8. South Korea
5.4.8.1. Key Country Dynamics
5.4.8.2. Competitive Scenario
5.4.8.3. Regulatory Framework
5.4.8.4. South Korea Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.5. Latin America
5.5.1. SWOT Analysis
5.5.2. Latin America Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.5.3. Brazil
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. Brazil Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.5.4. Mexico
5.5.4.1. Key Country Dynamics
5.5.4.2. Competitive Scenario
5.5.4.3. Regulatory Framework
5.5.4.4. Mexico Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.5.5. Argentina
5.5.5.1. Key Country Dynamics
5.5.5.2. Competitive Scenario
5.5.5.3. Regulatory Framework
5.5.5.4. Argentina Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.6. MEA
5.6.1. SWOT Analysis
5.6.2. MEA Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.6.3. South Africa
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. South Africa Tissue Engineering Market, 2018 - 2030 (USD Billion)
5.6.4. Saudi Arabia
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Framework
5.6.4.4. Saudi Arabia Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.6.5. UAE
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Framework
5.6.5.4. UAE Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
5.6.6. Kuwait
5.6.6.1. Key Country Dynamics
5.6.6.2. Competitive Scenario
5.6.6.3. Regulatory Framework
5.6.6.4. Kuwait Tissue Engineering Testing Market, 2018 - 2030 (USD Billion)
Chapter 6. Competitive Landscape
6.1. Company/Competition Categorization
6.2. Strategy Mapping
6.3. Key company market share analysis, 2022
6.4. Company Profiles/Listing
6.4.1. Zimmer Biomet Holdings, Inc.
6.4.1.1. Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. AbbVie (Allergan)
6.4.2.1. Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Becton, Dickinson and Company
6.4.3.1. Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. B. Braun
6.4.4.1. Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. Integra LifeSciences Corporation
6.4.5.1. Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Organogenesis Holdings Inc.
6.4.6.1. Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Medtronic
6.4.7.1. Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. ACell, Inc.
6.4.8.1. Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. Athersys, Inc.
6.4.9.1. Overview
6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Tissue Regenix Group plc
6.4.10.1. Overview
6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
6.4.11. Stryker Corporation
6.4.11.1. Overview
6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic Initiatives
6.4.12. RTI Surgical, Inc.
6.4.12.1. Overview
6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic Initiatives
6.4.13. ReproCell, Inc.
6.4.13.1. Overview
6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic Initiatives
6.4.14. Baxter International, Inc.
6.4.14.1. Overview
6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global tissue engineering market, by region, 2018 - 2030 (USD Billion)
Table 4 Global tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 5 North America tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 6 North America tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 7 U.S. tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 8 Canada tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 9 Europe tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 10 Europe tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 11 Germany tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 12 UK tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 13 France tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 14 Italy tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 15 Spain tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 16 Sweden tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 17 Norway tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 18 Denmark tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 19 Asia Pacific tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 20 APAC tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 21 China tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 22 Japan tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 23 India tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 24 Thailand tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 25 South Korea tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 26 Latin America tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 27 Latin America tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 28 Brazil tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 29 Mexico tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 30 Argentina tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 31 Middle East and Africa tissue engineering market, by country, 2018 - 2030 (USD Billion)
Table 32 Middle East and Africa tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 33 South Africa tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 34 Saudi Arabia tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 35 UAE tissue engineering market, by application, 2018 - 2030 (USD Billion)
Table 36 Kuwait tissue engineering market, by application, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Tissue engineering: market outlook
Fig. 9 Tissue engineering competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Tissue engineering market driver impact
Fig. 15 Tissue engineering market restraint impact
Fig. 16 Tissue engineering market strategic initiatives analysis
Fig. 17 Global tissue engineering market: Application movement analysis
Fig. 18 Global tissue engineering market: Application outlook and key takeaways
Fig. 19 Global cord blood & Cell Banking market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Global cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Global GI, Gynecology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Global dental market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Global skin & Integumentary market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Global urology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 Global orthopedics, Musculoskeletal, & Spine market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 26 Global neurology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 27 Global cardiology & Vascular market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Global others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Global tissue engineering market: Regional movement analysis
Fig. 30 Global tissue engineering market: Regional outlook and key takeaways
Fig. 31 Global market share and leading players
Fig. 32 North America market, SWOT analysis
Fig. 33 Europe market, SWOT analysis
Fig. 34 Asia Pacific market, SWOT analysis
Fig. 35 Latin America market, SWOT analysis
Fig. 36 Middle East & Africa market, SWOT analysis
Fig. 37 North America
Fig. 38 North America market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 39 U.S.
Fig. 40 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 41 Canada
Fig. 42 Canada market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 Europe
Fig. 44 Europe. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 UK
Fig. 46 UK market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Germany
Fig. 48 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 49 France
Fig. 50 France market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 51 Italy
Fig. 52 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Spain
Fig. 54 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 Sweden
Fig. 56 Sweden market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 Norway
Fig. 58 Norway market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 59 Denmark
Fig. 60 Denmark market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 61 Asia Pacific
Fig. 62 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 63 China
Fig. 64 China market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 65 Japan
Fig. 66 Japan market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 67 India
Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 69 Australia
Fig. 70 Australia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 71 Thailand
Fig. 72 Thailand market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 73 South Korea
Fig. 74 South Korea market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 75 Latin America
Fig. 76 Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 77 Brazil
Fig. 78 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 79 Mexico
Fig. 80 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 81 Argentina
Fig. 82 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 83 Middle East and Africa
Fig. 84 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 85 Saudi Arabia
Fig. 86 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 87 South Africa
Fig. 88 South Africa market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 89 UAE
Fig. 90 UAE market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 91 Kuwait
Fig. 92 Kuwait market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 93 Participant categorization- Tissue engineering market
Fig. 94 Market share of key market players- Tissue engineering market

Companies Mentioned

  • Zimmer Biomet Holdings, Inc.
  • AbbVie (Allergan)
  • Becton, Dickinson and Company
  • B. Braun
  • Integra LifeSciences Corporation
  • Organogenesis Holdings Inc.
  • Medtronic
  • ACell, Inc.
  • Athersys, Inc.
  • Tissue Regenix Group plc
  • Stryker Corporation
  • RTI Surgical, Inc.
  • ReproCell, Inc.
  • Baxter International, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 14.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 43.13 Billion
Compound Annual Growth Rate14.2%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Global Tissue Engineering Market by Product (Biomaterials, Equipment, Services), Application (Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development), End-User - Forecast 2024-2030 - Product Image

Global Tissue Engineering Market by Product (Biomaterials, Equipment, Services), Application (Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development), End-User - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Tissue Engineering Global Market Report 2024 - Product Image

Tissue Engineering Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Tissue Engineering Market by Product (Scaffolds (Collagen, Stem Cell), Tissue Grafts (Allograft, Autograft, Xenograft)), Material (Biological, Synthetic), Application (Orthopedics, Dermatology, Wound Care, Cardiovascular) - Forecast to 2028 - Product Image

Global Tissue Engineering Market by Product (Scaffolds (Collagen, Stem Cell), Tissue Grafts (Allograft, Autograft, Xenograft)), Material (Biological, Synthetic), Application (Orthopedics, Dermatology, Wound Care, Cardiovascular) - Forecast to 2028

  • Report
  • 344 Pages
  • Global
From
Tissue Engineering - Global Strategic Business Report - Product Image

Tissue Engineering - Global Strategic Business Report

  • Report
  • 97 Pages
  • Global
From
Tissue Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Tissue Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 178 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.